ADTX:US
$1.165
-2.101%
Aditxt Inc.News & Events
Last updated: Jul 15, 2025, 11:48 PM ET
Phexxi -- A Non?Hormonal Birth Control Brand -- Goes Viral with Microfeminism on TikTok, Featured by BuzzFeed and Scary Mommy
PR Newswire JUL 15, 2025 9:12 AM EDTPhexxi -- A Non‑Hormonal Birth Control Brand -- Goes Viral with Microfeminism on TikTok, F...READ ARTICLEAditxt Unveils bitXbio(TM): A Bitcoin-Backed Treasury Strategy Designed to Accelerate Biotech Commercialization
Business Wire JUL 7, 2025 8:15 AM EDTPlan Combines Bitcoin Treasury Strategy and Equity Line to Support 2026 Potential Monetization Ev...READ ARTICLEAditxt to Present at Wall Street Reporter's NEXT SUPER STOCK Livestream Today June 26, 2025, at 1 p.m. ET
Business Wire JUN 26, 2025 8:15 AM EDTAditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), a social innovation platform acceleratin...READ ARTICLEEvofem Biosciences' CEO Saundra Pelletier Joins Aditxt Board of Directors
Business Wire JUN 9, 2025 8:15 AM EDTAditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a social i...READ ARTICLESaundra Pelletier, Evofem Biosciences' CEO, Dr. Friedrich Kapp, Co-CEO of Adimune, and Chris Mitton, President of Pearsanta, Will Join Aditxt Weekly Update on June 6
Business Wire JUN 5, 2025 8:15 AM EDTAditxt, Inc. (Nasdaq: ADTX) (“Aditxt”), a social innovation platform accelerating...READ ARTICLEAppili Therapeutics Provides Update on Arrangement with Aditxt, Inc.
GlobeNewswire MAY 19, 2025 8:00 AM EDTNOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES...READ ARTICLEAditxt Announces Termination of Arrangement Agreement With Appili Therapeutics
Business Wire MAY 19, 2025 8:00 AM EDTWill eliminate approximately $16M in closing obligations Aditxt, Inc. (NASDAQ: ADTX) ...READ ARTICLEUpcoming Aditxt Weekly Update to Feature Dr. Shahrokh Shabahang, Chief Innovation Officer (CIO) of Aditxt(TM), and Dr. Friedrich Kapp, Co-CEO of Adimune(TM), to Discuss Progress of Lead Therapeutic Candidate ADI-100(TM)
Business Wire MAY 2, 2025 9:00 AM EDTEvent Begins Today at 11:30 a.m. ET Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "C...READ ARTICLEKILL Aditxt Subsidiary Adimune Announces Positive Results from Mayo Clinic Pre-Clinical Studies to Support FDA and European Regulatory Submissions for Type 1 Diabetes, Psoriasis, and Stiff Person Syndrome Human Trials
Business Wire APR 17, 2025 9:08 PM EDTAditxt, Inc. requests that their press release NewsItemId: 20250414955183 issued April 14, 2025 &...READ ARTICLEKILL Dr. Charles Howe of the Mayo Clinic's Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt's Subsidiary Adimune(TM)
Business Wire APR 17, 2025 9:03 PM EDTAditxt, Inc. requests that their press release NewsItemId: 20250417385764 “Dr. Charles How...READ ARTICLE